OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma
Juan Cai, Zhiqiang Chen, Yao Zhang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 755-771
Open Access | Times Cited: 66
Juan Cai, Zhiqiang Chen, Yao Zhang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 755-771
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 42
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 42
Circular RNA in cancer
Vanessa M. Conn, Arul M. Chinnaiyan, Simon J. Conn
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 597-613
Closed Access | Times Cited: 35
Vanessa M. Conn, Arul M. Chinnaiyan, Simon J. Conn
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 597-613
Closed Access | Times Cited: 35
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Feng Yang, Yang Liu, Jun Xiao, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 47
Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 34
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 34
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape
Yuxin Kong, Jie Yu, Shengfang Ge, et al.
The Innovation (2023) Vol. 4, Iss. 4, pp. 100452-100452
Open Access | Times Cited: 24
Yuxin Kong, Jie Yu, Shengfang Ge, et al.
The Innovation (2023) Vol. 4, Iss. 4, pp. 100452-100452
Open Access | Times Cited: 24
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis
Yameng Cui, Jingwen Liu, Lina Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 163-171
Closed Access | Times Cited: 28
Yameng Cui, Jingwen Liu, Lina Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 163-171
Closed Access | Times Cited: 28
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 19
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 19
N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy
Luo Ping, Shiqi Li, Xinghua Long
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188873-188873
Closed Access | Times Cited: 16
Luo Ping, Shiqi Li, Xinghua Long
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188873-188873
Closed Access | Times Cited: 16
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 6
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 6
Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma
Alyaa Dawoud, Ramez Elmasri, A.H. Mohamed, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104312-104312
Closed Access | Times Cited: 6
Alyaa Dawoud, Ramez Elmasri, A.H. Mohamed, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104312-104312
Closed Access | Times Cited: 6
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies
Chou‐Yi Hsu, Ahmed Faisal, Sally Salih Jumaa, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 970-994
Open Access | Times Cited: 5
Chou‐Yi Hsu, Ahmed Faisal, Sally Salih Jumaa, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 970-994
Open Access | Times Cited: 5
Effects of circulating RNAs on tumor metabolism in lung cancer (Review)
Pengfei Zhao, Zhengfeng Zhu, Xi Zheng, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-11
Open Access
Pengfei Zhao, Zhengfeng Zhu, Xi Zheng, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-11
Open Access
Role of the circRNA/miRNA/mRNA axis in Renal Cell Carcinoma: from gene regulation to metabolism and immunity
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4631-4631
Open Access | Times Cited: 20
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4631-4631
Open Access | Times Cited: 20
The role of m6A-mediated PD-1/PD-L1 in antitumor immunity
Li Liu, Long Liang, Hui Li, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115460-115460
Closed Access | Times Cited: 11
Li Liu, Long Liang, Hui Li, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115460-115460
Closed Access | Times Cited: 11
